JP2013529773A5 - - Google Patents

Download PDF

Info

Publication number
JP2013529773A5
JP2013529773A5 JP2013513743A JP2013513743A JP2013529773A5 JP 2013529773 A5 JP2013529773 A5 JP 2013529773A5 JP 2013513743 A JP2013513743 A JP 2013513743A JP 2013513743 A JP2013513743 A JP 2013513743A JP 2013529773 A5 JP2013529773 A5 JP 2013529773A5
Authority
JP
Japan
Prior art keywords
proteome
biomarkers
subject
sample
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013513743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013529773A (ja
JP6104796B2 (ja
Filing date
Publication date
Priority claimed from GBGB1009798.8A external-priority patent/GB201009798D0/en
Application filed filed Critical
Publication of JP2013529773A publication Critical patent/JP2013529773A/ja
Publication of JP2013529773A5 publication Critical patent/JP2013529773A5/ja
Application granted granted Critical
Publication of JP6104796B2 publication Critical patent/JP6104796B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013513743A 2010-06-11 2011-06-09 方法、アレイ、およびこれらの使用 Expired - Fee Related JP6104796B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1009798.8 2010-06-11
GBGB1009798.8A GB201009798D0 (en) 2010-06-11 2010-06-11 Method,array and use thereof
PCT/GB2011/000865 WO2011154698A2 (en) 2010-06-11 2011-06-09 Method,array and use thereof

Publications (3)

Publication Number Publication Date
JP2013529773A JP2013529773A (ja) 2013-07-22
JP2013529773A5 true JP2013529773A5 (https=) 2014-07-31
JP6104796B2 JP6104796B2 (ja) 2017-03-29

Family

ID=42471508

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013513743A Expired - Fee Related JP6104796B2 (ja) 2010-06-11 2011-06-09 方法、アレイ、およびこれらの使用

Country Status (11)

Country Link
US (2) US20130143760A1 (https=)
EP (1) EP2580592B1 (https=)
JP (1) JP6104796B2 (https=)
CN (1) CN103038642B (https=)
AU (1) AU2011263533B2 (https=)
BR (1) BR112012031444A2 (https=)
CA (1) CA2801863A1 (https=)
ES (1) ES2608956T3 (https=)
GB (1) GB201009798D0 (https=)
IN (1) IN2013CN00297A (https=)
WO (1) WO2011154698A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
US10928402B2 (en) 2012-12-28 2021-02-23 Nx Prenatal Inc. Treatment of spontaneous preterm birth
AU2015263998A1 (en) * 2014-05-22 2016-12-08 Northwestern University Gene expression profiles associated with sub-clinical kidney transplant rejection
US10443100B2 (en) 2014-05-22 2019-10-15 The Scripps Research Institute Gene expression profiles associated with sub-clinical kidney transplant rejection
BR112017007962A2 (pt) * 2014-10-24 2018-01-23 Koninklijke Philips Nv método implementado por computador, aparelho, mídia de armazenamento, programa de computador, kit, e, uso do kit
CA2976947C (en) * 2015-02-18 2023-02-28 Siemens Healthcare Diagnostics Inc. Locality-based detection of tray slot types and tube types in a vision system
TWI582240B (zh) * 2015-05-19 2017-05-11 鄭鴻鈞 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置
WO2017096405A1 (en) * 2015-12-04 2017-06-08 Nx Prenatal Inc. Use of circulating microparticles to stratify risk of spontaneous preterm birth
CN109444402B (zh) * 2018-12-18 2021-05-28 郑州安图生物工程股份有限公司 去甲肾上腺素发光免疫检测试剂盒

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12586T1 (de) 1980-05-02 1985-04-15 Edward P Davis Beinentlastungsgeraet.
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US5376531A (en) 1992-09-03 1994-12-27 Northwestern University Method of detecting cancer
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
EP1876241A3 (en) 1996-01-11 2008-07-30 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
RO114835B1 (ro) 1997-03-17 1999-07-30 Ioan Puşcaş Metodă rapidă de diagnostic al cancerelor
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
AUPP525198A0 (en) 1998-08-13 1998-09-03 Medvet Science Pty. Ltd. Monoclonal antibody inhibitor of GM-CSF, IL-3 and IL-5 and other cytokines and uses thereof
US6492505B1 (en) 1999-02-01 2002-12-10 Incyte Genomics, Inc. Composition for detection of genes encoding membrane-associated proteins
WO2002101357A2 (en) 2001-06-10 2002-12-19 Irm Llc Molecular signatures of commonly fatal carcinomas
AU2003284880A1 (en) 2002-10-24 2004-05-13 Duke University Evaluation of breast cancer states and outcomes using gene expression profiles
US20040087571A1 (en) 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
US20040259161A1 (en) 2003-03-12 2004-12-23 Fredrik Nilsson Screening assay
WO2004106495A2 (en) 2003-05-29 2004-12-09 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US20060019256A1 (en) 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
ATE491953T1 (de) * 2003-09-15 2011-01-15 Oklahoma Med Res Found Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
JP4443568B2 (ja) 2003-10-15 2010-03-31 エフ．ホフマン−ラ ロシュ アーゲー 乳癌に対するマーカーとしてのタンパク質ａｓｃの使用
WO2005080570A1 (ja) 2004-02-24 2005-09-01 Mitsubishi Rayon Co., Ltd. 乳癌の術後予後予測に関与する遺伝子
US20090166224A1 (en) 2004-05-05 2009-07-02 Ziping Yang Multi-lectin affinity chromatography and uses thereof
WO2006105642A1 (en) 2005-04-05 2006-10-12 British Columbia Cancer Agency Biomarkers for the detection of lung cancer and uses thereof
WO2007002069A2 (en) 2005-06-21 2007-01-04 Anthony Goncalves Serum biomarkers for breast cancer
US7972770B2 (en) 2005-08-16 2011-07-05 Memorial Sloan-Kettering Cancer Center Methods of detection of cancer using peptide profiles
EP1777523A1 (en) 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
US20080311601A1 (en) 2005-11-02 2008-12-18 Elting James J Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy
US9095549B2 (en) * 2005-12-16 2015-08-04 Electrophoretics Limited Diagnosis and prognosis of colorectal cancer
SG142186A1 (en) 2006-10-20 2008-05-28 Agency Science Tech & Res Breast tumour grading
WO2008117067A2 (en) 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
NZ562237A (en) 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
GB0723179D0 (en) 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
US20090239229A1 (en) * 2008-03-14 2009-09-24 Dnar, Inc DNA Repair Proteins Associated With Triple Negative Breast Cancers and Methods of Use Thereof
EP2105740A1 (en) * 2008-03-28 2009-09-30 Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. Biomarkers for monitoring or predicting the treatment of cancer
EP2281063B1 (en) 2008-04-29 2014-10-15 Siemens Healthcare Diagnostics GmbH A method for predicting a clinical response of a patient suffering from or at risk of developing cancer towards a given mode of treatment
JP2010151800A (ja) 2008-11-06 2010-07-08 Kumamoto Univ 生活習慣病及び／又は癌の診断剤
WO2010076322A1 (en) 2008-12-30 2010-07-08 Siemens Healthcare Diagnostics Inc. Prediction of response to taxane/anthracycline-containing chemotherapy in breast cancer
EP2391962B1 (en) 2009-01-28 2016-12-21 University of Notre Dame du Lac Accelerated progression relapse test
MX337650B (es) 2009-11-23 2016-03-14 Genomic Health Inc Metodos para predecir el desenlace clinico del cancer.
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
GB201410226D0 (en) 2014-06-09 2014-07-23 Immunovia Ab Methods and arrays for use in the same

Similar Documents

Publication Publication Date Title
JP2013529773A5 (https=)
WO2011154698A3 (en) Method,array and use thereof
Yakob et al. Salivary biomarkers for detection of oral squamous cell carcinoma: current state and recent advances
Laurinavicius et al. Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data
WO2015067969A3 (en) Method, array and use thereof for determining pancreatic cancer
Sun et al. Diagnosis and prognosis—review of biomarkers for mesothelioma
Bertucci et al. Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients
JP2011506917A5 (https=)
JP2009509171A5 (https=)
JP2015505370A5 (https=)
JP2017508970A5 (https=)
WO2017194613A3 (en) Method, array and use thereof
WO2016091888A3 (en) Methods, kits and compositions for phenotyping pancreatic ductal adenocarcinoma behaviour by transcriptomics
Li et al. Prognostic significance of cyclin D1 expression in renal cell carcinoma: a systematic review and meta-analysis
WO2012050365A3 (ko) 교모세포종의 진단 또는 예후 예측용 바이오 마커 및 그 용도
BR112013021056A2 (pt) anticorpo monoclonal, linhagem de células de hibridoma, kit para diagnóstico, métodos para a produção de um anticorpo monoclonal e de um agente de ligação, agente de ligação sequência de aminoácidos purificada, método para a obtenção de uma sequência do ácido nucleico codificante, molécula do ácido nucleico isolado codificante, vetor, célula hospedeira isolada, proteína de fusão, método de triagem para a presença de uma doença, de uma condição, métodos de diagnóstico de um indivíduo, de prognóstico para um indivíduo, e de monitoramento de um indivúdo, e, método para detecção da presença ou ausência de um câncer cervical
US20180284120A1 (en) Methods for determining a breast cancer-associated disease state and arrays for use in the methods
JP2015519043A5 (https=)
JP2016519767A5 (https=)
Shao et al. Prognostic role of high Bmi-1 expression in Asian and Caucasian patients with solid tumors: a meta-analysis
March-Villalba et al. Immunohistochemical expression of Ki-67, Cyclin D1, p16INK4a, and Survivin as a predictive tool for recurrence and progression-free survival in papillary urothelial bladder cancer pTa/pT1 G2 (WHO 1973)
Malinowsky et al. Targeted therapies in cancer-challenges and chances offered by newly developed techniques for protein analysis in clinical tissues
Zhang et al. Prognostic value of β-catenin expression in breast cancer patients: A meta-analysis
JP2006508326A5 (https=)
Suehara et al. Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics